US biotech uses AI to pick antiviral for COVID-19 trialUS biotech AI Therapeutics has begun a phase 2 trial of its LAM-002A, an antiviral drug that has Share XUS biotech uses AI to pick antiviral for COVID-19 trialhttps://pharmaphorum.com/news/ai-therapeutics-begins-mid-stage-trial-of-covid-19-antiviral/
